Outcomes of acute heart failure associated with acute coronary syndrome versus other causes

Acute Cardiac Care

Volumn 13, Issue 2, 2011, Pages 87-92

  Greenberg, Gabriel ^a,b   Cohen, Eytan ^c   Garty, Moshe ^c   Iakobishvili, Zaza ^a,b   Sandach, Amir ^d   Behar, Solomon ^e   Shotan, Avraham ^f   Gottlieb, Shmuel ^e,g   Mager, Aviv ^a,b   Battler, Alexander ^a,b   Hasdai, David ^a,b,c  

^a Beilinson Campus   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d BAR ILAN UNIVERSITY   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

^f HILLEL YAFFE MEDICAL CENTER   (Israel)

^g BIKUR CHOLIM HOSPITAL   (Israel)

Author keywords

acute coronary syndrome; Acute heart failure; outcome

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; SPIRONOLACTONE; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; DIURETICS; FEMALE; HEALTH SURVEYS; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; QUESTIONNAIRES; VASODILATOR AGENTS;

EID: 79958032697     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941.2011.567284     Document Type: Article

References (23)

1. American Heart Association. 2003 Heart and stroke statisticalupdate. Dallas (Tex): American Heart Association, 2002.
2. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290-95.
3. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-63. (Pubitemid 36286187)
4. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, et al. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003; 24:464-74. (Pubitemid 36286188)
5. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population. Eur Heart J. 2006;27:2725-36. (Pubitemid 44729876)
6. Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O ' Connor CM, She L, et al. OPTIMIZE-HF Investigators and Coordinators. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006;296:2217-26. (Pubitemid 44708052)
7. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ. ADHERE Scientifi c Advisory Committee Study Group and Investigators. Risk stratifi cation for in-hospital mortality in acutely decompensated heart failure: Classifi cation and regression tree analysis. JAMA 2005;293:572-80. (Pubitemid 40171239)
8. Hasdai D, Topol EJ, Kilaru R, Battler A, Harrington RA, Vahanian A, et al. Frequency, patient characteristics, and outcomes of mild to moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fi brinolytic therapy trials. Am Heart J. 2003;24:623-29.
9. Hasdai D, Holmes DR Jr, Califf RM, Thompson TD, Hochman JS, et al. Cardiogenic shock complicating acute myocardial infarction: Predictors of mortality. Am Heart J. 1999;138:21-31. (Pubitemid 29331116)
10. Hasdai D, Harrington RA, Hochman JS, Califf RM, Battler A, Box JW, et al. Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndrome without persistent ST-segment elevation. J Am Coll Cardiol. 2000; 36:685-92.
11. Haim M, Battler A, Behar S, Boyko V, Fioretti PM, Hasdai D. Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure. Does current treatment comply with guidelines? Am Heart J. 2004;147:859-64. (Pubitemid 38880998)
12. Iakobishvili Z, Behar S, Boyko V, Battler A, Hasdai D. Does current treatment of cardiogenic shock complicating the acute coronary syndromes comply with guidelines? Am Heart J. 2005; 149:98-103. (Pubitemid 40126496)
13. Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, et al. Levosimendan vs Dobutamine for patients with acute decompensated heart failure: The SURVIVE randomized trial. JAMA 2007;297:1883-91. (Pubitemid 46707842)
14. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission aft er hospitalization for congestive heart failure among Medicare benefi ciaries. Arch Intern Med. 1997;157:99-104. (Pubitemid 27027080)
15. Young JB, Abraham WT, Lynne Warner Stevenson, Horton DP, Elkayam U, et al., Publication Committee for the VMAC investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure. JAMA 2002;287:1531-40. (Pubitemid 34269998)
16. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. For the steering committee and investigators of the levosimendan infusion versus dobutamine (LIDO) study. Effi cacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomized double-blind trial. Lancet 2002;360:196-202. (Pubitemid 34804646)
17. Garty M, Shotan A, Gottlieb S, Mittelman M, Porath A, Lewis BS, et al. HFSIS steering committee and investigators. The management, early and one year outcome in hospitalized patients with heart failure: A national Heart Failure Survey in Israel-HFSIS 2003. Isr Med Assoc J. 2007;9:227-33. (Pubitemid 46692035)
18. Barsheshet A, Shotan A, Cohen E, Garty M, Goldenberg I, Sandach A, et al. HFSIS steering committee and investigators. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail. 2010;12:833-40.
19. Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, et al. Prevalence and signifi cance of unrecognized renal insuffi - ciency in patients with heart failure. Eur Heart J. 2008;29:1029-36. (Pubitemid 351844687)
20. Remme WJ, Swedberg K. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 2002;4:11-22. (Pubitemid 34113325)
21. Peacock WF IV, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al., for the ADHERE investigators. Cardiac tropo nin and outcome in acute heart failure. N Engl J Med. 2008; 358: 2117-26. (Pubitemid 351679598)
22. Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes. The ADHERE registry. Eur Heart J 2005;7;B13 - 9. (Pubitemid 40516891)
23. Myocardial infarction redefi ned - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefi nition of myocardial infarction. Eur Heart J. 2000;21:1502-13.